Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-27

Clinical Trial Update: Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder [NA]

View source ↗

Summary

A Pharmaco(Epi)Genetic, Proteomic, and Microbiomic study focusing on obsessive-compulsive disorder is currently recruiting. Sponsored by Severance Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Severance Hospital | Conditions: Obsessive-Compulsive Disorder | NA | Status: RECRUITING